Bioequivalence

In Vitro Dissolution for BCS Based Biowaiver Approach

In Vitro Dissolution for BCS Based Biowaiver Approach

  When applying the BCS based biowaiver approach, comparative in vitro dissolution tests should be conducted using one batch representative of the proposed commercial manufacturing process for the test product relative to the reference product.   The test product should originate from a batch of at least 1/10 of production scale or 100,000 units, whichever…

Understanding ANDA Process in the US FDA
| |

Understanding ANDA Process in the US FDA

The Abbreviated New Drug Application (ANDA) is a crucial regulatory pathway in the United States for the approval of generic drugs. This post provides a detailed overview of the ANDA process, its requirements, and significance in the pharmaceutical industry.   1. Purpose of ANDA ANDA allows pharmaceutical companies to demonstrate that their generic drug product…